Association Between Statin Use After Diagnosis of Esophageal Cancer and Survival: A Population-Based Cohort Study

Gastroenterology
Leo AlexandreAndrew R Hart

Abstract

Statins (3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors), commonly prescribed in the primary and secondary prevention of cardiovascular disease, promote apoptosis and limit proliferation of esophageal cancer cell lines. We investigated whether statin use after a diagnosis of esophageal cancer is associated with reduced esophageal cancer-specific and all-cause mortality. We identified a cohort of 4445 men and women in the United Kingdom diagnosed with esophageal cancer from January 2000 through November 2009 using the General Practice Research Database. The National Cancer Registry and Office of National Statistics datasets established the histologic subtype and cancer-specific mortality, respectively. Cox proportional hazard regression analysis with time-dependent exposures estimated the association between statin use after diagnosis and esophageal cancer-specific and all-cause mortality. The median survival time of the entire cohort was 9.2 months (interquartile range [IQR], 3.7-23.2 mo). Among subjects who used statins after a diagnosis of esophageal cancer, the median survival time was 14.9 months (IQR, 7.1-52.3 mo) compared with 8.1 months for nonusers (IQR, 3.3-20 mo). In the entire cohort, statin use after dia...Continue Reading

References

Jan 1, 1996·Annual Review of Biochemistry·F L Zhang, P J Casey
Jun 27, 1998·British Journal of Clinical Pharmacology·L A García Rodríguez, S Pérez Gutthann
Apr 23, 1999·Lancet·T Walley, A Mantgani
May 14, 2003·Pharmacotherapy·Susan S JickHershel Jick
Jan 26, 2005·British Journal of Cancer·R DollI Sutherland
Dec 6, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Yi-Chu LinChing-Chow Chen
Dec 7, 2007·American Journal of Epidemiology·Samy Suissa
Mar 29, 2008·The American Journal of Gastroenterology·Olorunseun O Ogunwobi, Ian L P Beales
May 31, 2008·BMJ : British Medical Journal·Angela CooperUNKNOWN Guideline Development Group
Nov 14, 2008·The New England Journal of Medicine·T PischonE Riboli
Feb 8, 2011·CA: a Cancer Journal for Clinicians·Ahmedin JemalDavid Forman
Sep 20, 2011·Pharmacoepidemiology and Drug Safety·Alexander M Walker
Oct 22, 2011·The Journal of Thoracic and Cardiovascular Surgery·Miral R SadariaMichael J Weyant
Aug 25, 2012·Gut·Gustaf EdgrenOlof Nyrén
Nov 9, 2012·The New England Journal of Medicine·Sune F NielsenStig E Bojesen
Nov 28, 2012·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Jianxin ShiFeng Yao
Nov 6, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Oriana YuLaurent Azoulay
Aug 6, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Chris R CardwellLiam J Murray

❮ Previous
Next ❯

Citations

Oct 21, 2016·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Gregoire F Le BrasClaudia D Andl
Oct 25, 2016·Biochimica Et Biophysica Acta·Ji ChengWenyi Wei
Feb 28, 2017·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michael J SecklAllan Hackshaw
Jun 21, 2018·International Journal of Cancer. Journal International Du Cancer·Cecilie D SperlingSusanne K Kjaer
Jan 22, 2020·Journal of the American Heart Association·Maria Isabel Camara PlanekTochukwu M Okwuosa
Aug 12, 2020·Veterinary and Comparative Oncology·Kosuke KobayashiMasaru Okuda
Nov 20, 2016·International Journal of Cancer. Journal International Du Cancer·Zubing MeiWei Yang
Dec 7, 2017·PharmacoEconomics·Rebekah Fong Soe KhioeLeo Alexandre
May 14, 2019·United European Gastroenterology Journal·Juntaro MatsuzakiTakanori Kanai
Feb 15, 2021·Molecular and Cellular Biochemistry·Ian L P Beales, Olorunseun O Ogunwobi
Feb 26, 2021·Nature·Caroline Perry, Ulf H Beier
Mar 16, 2021·Frontiers in Oncology·Borja GuerraLeandro Fernández-Pérez
May 2, 2021·Journal of Gastrointestinal Cancer·Jonathan V S Wong, Ali Fatehi Hassanabad
Jun 1, 2021·Journal of Gastrointestinal Cancer·Ali Fatehi Hassanabad, Jonathan V S Wong

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis